Latest Regulatory News

Auswide Bank’s acquisition by MyState Bank has reached a key milestone with the scheme of arrangement now legally effective, triggering a suspension of Auswide’s shares and setting the stage for shareholder transitions.

Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.

KALINA Power has significantly expanded its land holdings in Alberta, boosting its potential Power-CCS capacity to 1.7 GW to meet surging demand for data centre power solutions with carbon capture.

WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.

8VI Holdings Limited has requested an immediate voluntary suspension of its securities on the ASX, paving the way for its planned delisting on 13 February 2025.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Arovella Therapeutics has requested a voluntary suspension of its ASX-listed securities pending a material announcement on a capital raising, expected by 17 February 2025.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

S2 Resources has initiated its first aircore drilling campaign at the Yeungroon project, aiming to delineate gold-arsenic hotspots along the extensive O'Connors trend. Results are expected by April 2025, potentially unlocking new opportunities in Victoria’s historic goldfields.

Scorpion Minerals Limited has voluntarily suspended trading of its shares as it finalises a capital raising and a potential joint venture agreement, signaling significant corporate developments ahead.

BlinkLab has secured North Shore Pediatric Therapy as the second US clinical site in its autism diagnostic study, enhancing recruitment and data quality with a leading Chicago-based specialist.